Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia
Lena Blümel(German Cancer Research Center), Ute Fischer(Dortmund University of Applied Sciences and Arts), Beat Bornhäuser(University Children's Hospital Zurich), Martin Stanulla(Leibniz University Hannover), Arndt Borkhardt(Düsseldorf University Hospital), Nan Qin(China Pharmaceutical University), Vera H. Jepsen(Heinrich Heine University Düsseldorf), Jasmin Bartl(Universität Hamburg), Sanil Bhatia(University Medical Center), Marc Remke(Saarland University), Florent Dingli(Institut Curie), Julian Schliehe‐Diecks(Heinrich Heine University Düsseldorf), Véronique Marsaud(Université Paris-Sud), Daniel Picard(Heidelberg University), Flavia Bernardi(Université Paris-Sud), Rebecca Hasselmann(Düsseldorf University Hospital), Blerim Marovka(University Children's Hospital Zurich), Jean-Pierre Bourqin(University Children's Hospital Zurich), Olivier Ayrault(St. Jude Children's Research Hospital), Jacob Torrejon Diaz(Université Paris-Sud), Damarys Loew(Institut Curie)
Cited by 2
Related Papers
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k